Global Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 93
Published Date: 29 Jun 2023
Category: Chemical & Material
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
According to our (Global Info Research) latest study, the global Nicotinamide Mononucleotide (NMN) market size was valued at USD 306.1 million in 2022 and is forecast to a readjusted size of USD 679.1 million by 2029 with a CAGR of 12.1% during review period.
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
Global key players of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirailab Bioscience, EffePharm, Herbalmax and Genex Formulas. Asia-Pacific is the largest producer, holds a share over 60%, followed by North America and Europe. In terms of product type, content greater than or equal to 98% is the largest segment, with a share over 99%. And in terms of application, the largest segment is Health Care Products, with a share over 99%.
The Global Info Research report includes an overview of the development of the Nicotinamide Mononucleotide (NMN) industry chain, the market status of Health Care Products (Content Greater than or Equal to 98%, Content Less than 98%), Cosmetics (Content Greater than or Equal to 98%, Content Less than 98%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nicotinamide Mononucleotide (NMN).
Regionally, the report analyzes the Nicotinamide Mononucleotide (NMN) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nicotinamide Mononucleotide (NMN) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nicotinamide Mononucleotide (NMN) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nicotinamide Mononucleotide (NMN) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kg), revenue generated, and market share of different by Type (e.g., Content Greater than or Equal to 98%, Content Less than 98%).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nicotinamide Mononucleotide (NMN) market.
Regional Analysis: The report involves examining the Nicotinamide Mononucleotide (NMN) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nicotinamide Mononucleotide (NMN) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nicotinamide Mononucleotide (NMN):
Company Analysis: Report covers individual Nicotinamide Mononucleotide (NMN) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nicotinamide Mononucleotide (NMN) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Health Care Products, Cosmetics).
Technology Analysis: Report covers specific technologies relevant to Nicotinamide Mononucleotide (NMN). It assesses the current state, advancements, and potential future developments in Nicotinamide Mononucleotide (NMN) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nicotinamide Mononucleotide (NMN) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Content Greater than or Equal to 98%
Content Less than 98%
Market segment by Application
Health Care Products
Cosmetics
Others
Major players covered
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of Nicotinamide Mononucleotide (NMN) from 2018 to 2023.
Chapter 3, the Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nicotinamide Mononucleotide (NMN) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nicotinamide Mononucleotide (NMN).
Chapter 14 and 15, to describe Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Nicotinamide Mononucleotide (NMN)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Nicotinamide Mononucleotide (NMN) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Content Greater than or Equal to 98%
1.3.3 Content Less than 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Nicotinamide Mononucleotide (NMN) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Health Care Products
1.4.3 Cosmetics
1.4.4 Others
1.5 Global Nicotinamide Mononucleotide (NMN) Market Size & Forecast
1.5.1 Global Nicotinamide Mononucleotide (NMN) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Nicotinamide Mononucleotide (NMN) Sales Quantity (2018-2029)
1.5.3 Global Nicotinamide Mononucleotide (NMN) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Product and Services
2.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GeneHarbor Recent Developments/Updates
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Product and Services
2.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Herbalmax Recent Developments/Updates
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Product and Services
2.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genex Formulas Recent Developments/Updates
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Product and Services
2.4.4 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product and Services
2.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Maac10 Formulas Recent Developments/Updates
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Product and Services
2.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 EffePharm Recent Developments/Updates
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac Nicotinamide Mononucleotide (NMN) Product and Services
2.7.4 Bontac Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bontac Recent Developments/Updates
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Product and Services
2.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CELFULL Recent Developments/Updates
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Product and Services
2.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kingdomway Recent Developments/Updates
3 Competitive Environment: Nicotinamide Mononucleotide (NMN) by Manufacturer
3.1 Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2018-2023)
3.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Nicotinamide Mononucleotide (NMN) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
3.4.2 Top 6 Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
3.5 Nicotinamide Mononucleotide (NMN) Market: Overall Company Footprint Analysis
3.5.1 Nicotinamide Mononucleotide (NMN) Market: Region Footprint
3.5.2 Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
3.5.3 Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Nicotinamide Mononucleotide (NMN) Market Size by Region
4.1.1 Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
4.1.2 Global Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
4.1.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Region (2018-2029)
4.2 North America Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.3 Europe Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.4 Asia-Pacific Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.5 South America Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.6 Middle East and Africa Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
5.2 Global Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2018-2029)
5.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
6.2 Global Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2018-2029)
6.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2029)
7 North America
7.1 North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
7.2 North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
7.3 North America Nicotinamide Mononucleotide (NMN) Market Size by Country
7.3.1 North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
7.3.2 North America Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
8.2 Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
8.3 Europe Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.1 Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
8.3.2 Europe Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Nicotinamide Mononucleotide (NMN) Market Size by Region
9.3.1 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
10.2 South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
10.3 South America Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
10.3.2 South America Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Nicotinamide Mononucleotide (NMN) Market Size by Country
11.3.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Nicotinamide Mononucleotide (NMN) Market Drivers
12.2 Nicotinamide Mononucleotide (NMN) Market Restraints
12.3 Nicotinamide Mononucleotide (NMN) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Nicotinamide Mononucleotide (NMN) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nicotinamide Mononucleotide (NMN)
13.3 Nicotinamide Mononucleotide (NMN) Production Process
13.4 Nicotinamide Mononucleotide (NMN) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nicotinamide Mononucleotide (NMN) Typical Distributors
14.3 Nicotinamide Mononucleotide (NMN) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Nicotinamide Mononucleotide (NMN) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 4. GeneHarbor Major Business
Table 5. GeneHarbor Nicotinamide Mononucleotide (NMN) Product and Services
Table 6. GeneHarbor Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GeneHarbor Recent Developments/Updates
Table 8. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 9. Herbalmax Major Business
Table 10. Herbalmax Nicotinamide Mononucleotide (NMN) Product and Services
Table 11. Herbalmax Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Herbalmax Recent Developments/Updates
Table 13. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 14. Genex Formulas Major Business
Table 15. Genex Formulas Nicotinamide Mononucleotide (NMN) Product and Services
Table 16. Genex Formulas Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Genex Formulas Recent Developments/Updates
Table 18. Shinkowa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Shinkowa Pharmaceutical Major Business
Table 20. Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Product and Services
Table 21. Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shinkowa Pharmaceutical Recent Developments/Updates
Table 23. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 24. Maac10 Formulas Major Business
Table 25. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product and Services
Table 26. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Maac10 Formulas Recent Developments/Updates
Table 28. EffePharm Basic Information, Manufacturing Base and Competitors
Table 29. EffePharm Major Business
Table 30. EffePharm Nicotinamide Mononucleotide (NMN) Product and Services
Table 31. EffePharm Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. EffePharm Recent Developments/Updates
Table 33. Bontac Basic Information, Manufacturing Base and Competitors
Table 34. Bontac Major Business
Table 35. Bontac Nicotinamide Mononucleotide (NMN) Product and Services
Table 36. Bontac Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bontac Recent Developments/Updates
Table 38. CELFULL Basic Information, Manufacturing Base and Competitors
Table 39. CELFULL Major Business
Table 40. CELFULL Nicotinamide Mononucleotide (NMN) Product and Services
Table 41. CELFULL Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. CELFULL Recent Developments/Updates
Table 43. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 44. Kingdomway Major Business
Table 45. Kingdomway Nicotinamide Mononucleotide (NMN) Product and Services
Table 46. Kingdomway Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Kingdomway Recent Developments/Updates
Table 48. Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2018-2023) & (Kg)
Table 49. Global Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 51. Market Position of Manufacturers in Nicotinamide Mononucleotide (NMN), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Nicotinamide Mononucleotide (NMN) Production Site of Key Manufacturer
Table 53. Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
Table 54. Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
Table 55. Nicotinamide Mononucleotide (NMN) New Market Entrants and Barriers to Market Entry
Table 56. Nicotinamide Mononucleotide (NMN) Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
Table 58. Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
Table 59. Global Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Nicotinamide Mononucleotide (NMN) Average Price by Region (2018-2023) & (US$/Kg)
Table 62. Global Nicotinamide Mononucleotide (NMN) Average Price by Region (2024-2029) & (US$/Kg)
Table 63. Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 64. Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 65. Global Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Nicotinamide Mononucleotide (NMN) Average Price by Type (2018-2023) & (US$/Kg)
Table 68. Global Nicotinamide Mononucleotide (NMN) Average Price by Type (2024-2029) & (US$/Kg)
Table 69. Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 70. Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 71. Global Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2023) & (US$/Kg)
Table 74. Global Nicotinamide Mononucleotide (NMN) Average Price by Application (2024-2029) & (US$/Kg)
Table 75. North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 76. North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 77. North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 78. North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 79. North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
Table 80. North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
Table 81. North America Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 84. Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 85. Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 86. Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 87. Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
Table 88. Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
Table 89. Europe Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 92. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 93. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 94. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 95. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
Table 96. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
Table 97. Asia-Pacific Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 100. South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 101. South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 102. South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 103. South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
Table 104. South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
Table 105. South America Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 108. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 109. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 110. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 111. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
Table 112. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
Table 113. Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Nicotinamide Mononucleotide (NMN) Raw Material
Table 116. Key Manufacturers of Nicotinamide Mononucleotide (NMN) Raw Materials
Table 117. Nicotinamide Mononucleotide (NMN) Typical Distributors
Table 118. Nicotinamide Mononucleotide (NMN) Typical Customers
List of Figures
Figure 1. Nicotinamide Mononucleotide (NMN) Picture
Figure 2. Global Nicotinamide Mononucleotide (NMN) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Type in 2022
Figure 4. Content Greater than or Equal to 98% Examples
Figure 5. Content Less than 98% Examples
Figure 6. Global Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Application in 2022
Figure 8. Health Care Products Examples
Figure 9. Cosmetics Examples
Figure 10. Others Examples
Figure 11. Global Nicotinamide Mononucleotide (NMN) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Nicotinamide Mononucleotide (NMN) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Nicotinamide Mononucleotide (NMN) Sales Quantity (2018-2029) & (Kg)
Figure 14. Global Nicotinamide Mononucleotide (NMN) Average Price (2018-2029) & (US$/Kg)
Figure 15. Global Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Nicotinamide Mononucleotide (NMN) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Nicotinamide Mononucleotide (NMN) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Nicotinamide Mononucleotide (NMN) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Nicotinamide Mononucleotide (NMN) Average Price by Type (2018-2029) & (US$/Kg)
Figure 30. Global Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2029) & (US$/Kg)
Figure 33. North America Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
Figure 53. China Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Nicotinamide Mononucleotide (NMN) Market Drivers
Figure 74. Nicotinamide Mononucleotide (NMN) Market Restraints
Figure 75. Nicotinamide Mononucleotide (NMN) Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN) in 2022
Figure 78. Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN)
Figure 79. Nicotinamide Mononucleotide (NMN) Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
GeneHarbor Herbalmax Genex Formulas Shinkowa Pharmaceutical Maac10 Formulas EffePharm Bontac CELFULL Kingdomway
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>